Send us Feedback

AstraZeneca (AZN)
Analysis
Data
Financials
 
 
Balance Sheet    (USD)
Annual | Quarterly
QUARTER ENDING older 30-SEP
2008		 31-DEC
2008		 31-MAR
2009		 30-JUN
2009		 30-SEP
2009		 newer
Cash & Equivalents 3.54B 4.29B 4.44B 7.20B 7.79B
Short Term Investments 82.0M 388M 49.0M 42.0M 40.0M
Accounts Receivable 9.89B 9.16B 9.66B 9.98B 10.8B
Inventories 2.08B 1.64B 1.70B 1.87B 1.90B
Pre-paid Expenses 0 681M 0 0 0
Deferred Tax Assets 0 0 0 0 0
Other Current Assets 0 0 0 38.0M 0
Total Current Assets 15.6B 16.2B 15.9B 19.1B 20.5B
Property, Plant & Equipment 7.83B 7.04B 6.82B 7.26B 7.36B
Goodwill & Intangibles 23.1B 22.2B 21.9B 22.0B 22.1B
Other Long-term Assets 179M 156M 565M 456M 534M
Total Long-Term Assets 32.5B 30.6B 30.7B 31.1B 31.4B
Total Assets 48.1B 46.8B 46.5B 50.2B 51.9B
Accounts Payable 6.94B 3.90B 7.15B 7.37B 7.38B
Accrued Expenses 0 0 0 0 0
Short Term Debt 2.55B 993M 1.63B 1.50B 980M
Other Current Liabilities 4.89B 6.55B 5.27B 6.28B 6.75B
Total Current Liabilities 14.4B 13.3B 14.0B 15.1B 15.1B
Long Term Debt 10.8B 10.9B 10.1B 10.3B 10.5B
Capital Lease Obligations 0 0 0 0 0
Deferred Income Tax 3.86B 3.13B 3.11B 3.17B 3.27B
Other Long-term Liabilities 2.77B 3.42B 3.69B 3.62B 3.43B
Total Long-term Liabilities 17.5B 17.4B 16.9B 17.1B 17.2B
Minority Interest 127M 148M 146M 146M 159M
Total Liabilities 32.0B 30.9B 31.1B 32.4B 32.5B
Preferred Stock 0 0 0 0 0
Common Par 362M 362M 362M 362M 363M
Additional Paid-In Capital 2.00B 2.05B 0 2.06B 2.13B
Retained Earnings 11.8B 11.6B 11.0B 13.4B 15.0B
Treasury Stock 0 0 0 0 0
Other Equity 1.92B 1.93B 4.00B 1.93B 1.91B
Total Shareholder's Equity 16.1B 15.9B 15.4B 17.8B 19.4B
 
 
 
 
 
Data Sources:
Market and financial statement data provided by NASDAQ, BATS Exchange, SEC and Xignite Inc. Industry and operating metrics collected from company filings via EDGAR online. For more information on sources and calculations click here.
Wikinvest © 2006, 2007, 2008, 2009. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki